Skip to content Skip to footer
Subscribe Now
Viewpoints_Glenn Mattes
VIEWPOINTS

PharmaShots Interview: TFF Pharmaceuticals’s Glenn Mattes Shares Insights on the Thin Film Freezing Technology

In an interview with PharmaShots, Glenn Mattes, President, CEO, and Director at TFF Pharmaceuticals share his views on the thin film freezing technology for the development of vaccines and therapeutics against multiple infectious diseases including IPAShots:The company focuses on developing and commercializing innovative drug products based on its patented TFF technology platform including the development of vaccines and therapeutics against multiple infectious…
December 8, 2021

Read more

Viewpoints_Dr. Dale Christensen
VIEWPOINTS

PharmaShots Interview: TFF’s Dr. Dale Christensen Shares Insight on the Thin Film Freezing Technology

In an interview with PharmaShots, Dr. Dale Christensen, Ph.D., Director of Clinical Development at TFF Pharmaceuticals shared his views on the preliminary data from the P-I trial of inhalable tacrolimus powder formulation for Lung Transplant & its TFF technologyShots:TFF has developed an inhalable tacrolimus powder formulation that can be delivered directly to the lung via an inhaler bypassing…
September 15, 2021

Read more